CONTINEUM THERAPEUTICS INC

Contineum Therapeutics beats earnings but faces a cautious outlook as analysts adjust price targets. Learn how the company’s CNS focus and investor sentiment shape its future.

Contineum Therapeutics is a clinical-stage biopharmaceutical company advancing breakthrough therapies in neuroscience and immunology, with a promising pipeline of novel treatments for conditions such as idiopathic pulmonary fibrosis and multiple scl…